Lower levels of two anabolic growth mediators, (IGF and GH), and a higher level of the catabolic cytokine IL-6 were observed in this study and point to an imbalance which could contribute to some of the myopathies and growth delays present in BTHS patients. This evidence concerns the gene IGF1 and myopathy.